Clinical studies recruiting near Honolulu

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · The Queen's Medical Center · Joseph Broderick, MD · NCT07227246 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Hawaii Cancer Care Inc - Waterfront Plaza · National Cancer Institute (NCI) · NCT05564390 Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemi
NA · Queen's Medical Center · M.D. Anderson Cancer Center · NCT02945579 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Kapiolani Medical Center for Women and Children · National Cancer Institute (NCI) · NCT05099003 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Kapiolani Medical Center for Women and Children · National Cancer Institute (NCI) · NCT06172296 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Hawaii Cancer Care Inc - Waterfront Plaza · NRG Oncology · NCT05624996 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · Kapi'olani Medical Center for Women and Children · PedAL BCU, LLC · NCT05183035 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Kapiolani Medical Center for Women and Children · Children's Oncology Group · NCT06368817 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Kapiolani Medical Center for Women and Children · National Cancer Institute (NCI) · NCT05691478 Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Phase 2 · Kapiolani Medical Center for Women and Children · Giselle Sholler · NCT02559778 A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis
Phase 4 · The Queen's Medical Center - West Oahu · argenx · NCT06909214 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Kapiolani Medical Center for Women and Children · Alliance for Clinical Trials in Oncology · NCT07091617 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Phase 3 · Hawaii Pacific Neuroscience, Merz Investigational Site #0010 · Merz Therapeutics GmbH · NCT07018700 Study of Student Flourishing
NA · University of Hawai'i at Mānoa · Flourish Science, Inc. · NCT07259746 The Development and Evaluation of a Culturally Grounded ENDS Intervention for Rural Hawaiian Youth
NA · University of Hawaii · University of Hawaii · NCT06929520 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Kapiolani Medical Center for Women and Children · Children's Oncology Group · NCT04322318 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Hawaii Cancer Care Inc - Waterfront Plaza · NRG Oncology · NCT05946213 Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Ca
Phase N/A · Kapiolani Womens and Childrens Medical Center · Duke University · NCT04278404 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Hawaii Cancer Care Inc - Waterfront Plaza · NRG Oncology · NCT05174169 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Kaiser Permanente Moanalua Medical Center · Alliance for Clinical Trials in Oncology · NCT06632327 Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati
Phase 3 · Kaiser Permanente Moanalua Medical Center · Alliance for Clinical Trials in Oncology · NCT06931340 A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes
Phase N/A · University of Hawaii Cancer Center · Bristol-Myers Squibb · NCT05489705 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Kaiser Permanente Moanalua Medical Center /ID# 238363 · AbbVie · NCT04928846 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Kaiser Permanente Moanalua Medical Center · Alliance for Clinical Trials in Oncology · NCT06876714 GEMINI-NSCLC: NSCLC Biomarker Study
Phase N/A · Hawaii Cancer Care · Tempus AI · NCT05236114 Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of
Phase 3 · Research Site · AstraZeneca · NCT06921785 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Hawaii Cancer Care Inc - Waterfront Plaza · Canadian Cancer Trials Group · NCT06592924 A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H
Phase 2/Phase 3 · Pacific Diabetes & Endocrine Center /ID# 259030 · AbbVie · NCT06345339 Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Phase 1/Phase 2 · Kapiolani Medical Center for Women and Children · Milton S. Hershey Medical Center · NCT06541262 A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed A
Phase 3 · Kapiolani Medical Center for Women and Children · Children's Oncology Group · NCT04293562

Look up another city

Look up another condition